Episode 119 - Erik van den Berg - CEO of Memo Therapeutics episode artwork

EPISODE · Feb 16, 2026 · 24 MIN

Episode 119 - Erik van den Berg - CEO of Memo Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Prior to JPM 2026 and the news of their recent CSL collaboration, I spoke to Memo Therapeutics' CEO, Erik van den Berg for an episode of The BioHub Podcast.Memo are preparing for a global ph3 trial of Potravitug, their antibody against BK polyomavirus infection in kidney transplant recipients. BKPyV infection can lead to nephropathy, loss of kidney function, as well as organ failure, rejection & death, with the virus residing in up to 90% of the total population.Erik joins us to walk through Memo's late-stage plans, as well as their DROPZYLLA platform, and their early stage oncology programs. He also shares his insight from a varied journey through biotech leadership, including two current Chair roles with former BioHub guests - TargED & Step Pharma.

Prior to JPM 2026 and the news of their recent CSL collaboration, I spoke to Memo Therapeutics' CEO, Erik van den Berg for an episode of The BioHub Podcast.Memo are preparing for a global ph3 trial of Potravitug, their antibody against BK polyomavirus infection in kidney transplant recipients. BKPyV infection can lead to nephropathy, loss of kidney function, as well as organ failure, rejection & death, with the virus residing in up to 90% of the total population.Erik joins us to walk through Memo's late-stage plans, as well as their DROPZYLLA platform, and their early stage oncology programs. He also shares his insight from a varied journey through biotech leadership, including two current Chair roles with former BioHub guests - TargED & Step Pharma.

NOW PLAYING

Episode 119 - Erik van den Berg - CEO of Memo Therapeutics

0:00 24:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 24 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on February 16, 2026.

What is this episode about?

Prior to JPM 2026 and the news of their recent CSL collaboration, I spoke to Memo Therapeutics' CEO, Erik van den Berg for an episode of The BioHub Podcast.Memo are preparing for a global ph3 trial of Potravitug, their antibody against BK...

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!